Therapeutic approaches to counteract immediate blood-mediated inflammatory reaction in islet transplantation

Transplantation

Volumn 82, Issue 3, 2006, Pages 312-313

  Inverardi, Luca ^a   Ricordi, Camillo ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD39 ANTIGEN; DECAY ACCELERATING FACTOR; DEXTRAN; HEPARIN; MELAGATRAN;

ALLOIMMUNITY; BLOOD; BLOOD CLOTTING; CLINICAL TRIAL; COMPLEMENT ACTIVATION; DIABETES MELLITUS; DRUG POTENCY; GENE OVEREXPRESSION; GENE THERAPY; GLUCOSE METABOLISM; HUMAN; IMMEDIATE BLOOD MEDIATED INFLAMMATORY REACTION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NONHUMAN; NOTE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC THERAPY; XENOTRANSPLANTATION;

ANIMALS; GRAFT REJECTION; HUMANS; INFLAMMATION; ISLETS OF LANGERHANS TRANSPLANTATION; TIME FACTORS;

EID: 33747126801     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000228879.22020.0f     Document Type: Note

References (13)

1. Bennet W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999; 48: 1907.
2. Bennet W, Sundberg B, Lundgren T, et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000; 69: 711.
3. Bennet W, Groth CG, Larsson R, et al. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 2000; 105: 125.
4. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54: 1755.
5. Bertuzzi F, Marzorati S, Maffi P, et al. Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J Clin Endocrinol Metab 2004; 89: 5724.
6. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360(9350): 2039.
7. Goto M, Johansson H, Maeda A, et al. Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets. Transplantation 2004; 77: 741.
8. Ozmen L, Ekdahl KN, Elgue G, et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002; 51: 1779.
9. Dwyer KM, Mysore TB, Crikis S, et al. The transgenic expression of human CD39 on murine islets inhibits clotting of human blood. Transplantation 2006; 81: 428.
10. Salehi A, Quader SS, Grapengiesser E, Hellman B. Inhibition of Purinoceptors Amplifies Glucose-Stimulated Insulin Release with Removal of its Pulsatility. Diabetes 2006; 54: 2126.
11. White DJ, Yannoutsos N. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man. Res Immunol 1996; 147: 88.
12. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301.
13. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304.